Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Utah

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Utah. What Utah requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Utah at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Utah

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Utah (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Utah

Utah's telehealth practice standard is Utah Code section 26B-4-704 (renumbered and amended in 2023). It defines telemedicine services as care delivered through asynchronous store and forward transfer or synchronous interaction, and defines asynchronous store and forward transfer as transmission of a patient's health care information from an originating site to a provider at a distant site. A provider offering telehealth must act within the scope of the provider's license, meet the same standards of practice as in a traditional setting, establish a provider-patient relationship during the patient encounter if none exists, and, before treating or prescribing, establish a diagnosis and identify underlying conditions and contraindications after obtaining and documenting the patient's relevant clinical history and current symptoms. Subsection (4) bars diagnosing, treating, or prescribing based solely on an online questionnaire, an email message, or a patient-generated medical history. Division of Professional Licensing rule R156-1-602 adds identity verification, informed consent, and a ban on restricting the patient's choice of pharmacy. The prescriber must hold a Utah license in good standing. GLP-1 medicines and the peptides in this database are not controlled substances. This record classifies asynchronous prescribing as unresolved because the law is ambiguous: the statute counts store and forward as a telemedicine method and no provision requires a live visit, but it never says the relationship may be formed that way, and its bar on relying solely on patient-generated history leaves unclear what an asynchronous intake must add. [2] [3]

Compounded GLP-1 access in Utah

Patients using an out-of-state telehealth program should confirm the shipping pharmacy holds a Utah Class D license, which the DOPL license lookup shows. [1] [5] [7]

Research use only sellers in Utah

The Utah Pharmacy Practice Act (title 58, chapter 17b) limits dispensing of prescription drugs to licensed pharmacies, so a seller shipping "research use only" injectable peptides to Utah consumers is not a licensed pharmacy. [4] [8]

How to check a telehealth provider in Utah

  1. Confirm the prescriber is licensed or registered to treat patients located in Utah; the telehealth rules above explain what Utah requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the Utah State Board of Pharmacy (Utah Division of Professional Licensing, Department of Commerce) license lookup. [1] [4] [5] [6]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Utah. [4] [8]

Common questions in Utah

Can I get a GLP-1 prescription in Utah through telehealth?

Yes. Utah Code section 26B-4-704 allows a Utah-licensed provider to treat and prescribe by telehealth under the same standards as an office visit. Before prescribing, the provider must obtain and document your relevant clinical history and current symptoms, establish a diagnosis, and identify underlying conditions and contraindications. The provider may not diagnose, treat, or prescribe based solely on an online questionnaire, an email message, or a patient-generated medical history. [2]

Does Utah allow asynchronous (store and forward) telehealth?

Utah law does not settle whether a prescription can be issued without a live visit. Section 26B-4-704 defines telemedicine services as using asynchronous store and forward transfer or synchronous interaction, and no provision requires a live visit. But the statute never says the provider-patient relationship may be formed by store and forward. It does bar diagnosing, treating, or prescribing based solely on an online questionnaire, an email message, or a patient-generated medical history. [2]

What license does an online pharmacy need to ship compounded peptides to Utah?

A Utah Class D pharmacy license, which covers nonresident mail order and online retail pharmacies. A Class D pharmacy that compounds must follow USP chapters 795 and 797 under rule R156-17b-616, and applicants submit a recent state or NABP inspection. [1] [5]

All peptide legal questions for Utah

Sources

  1. [1]Utah Division of Professional Licensing: Pharmacy (Utah State Board of Pharmacy)
  2. [2]Utah Code section 26B-4-704, Scope of telehealth practice
  3. [3]Utah Administrative Code R156-1-602, Telehealth (General Rule of the Division of Professional Licensing)
  4. [4]Utah Code title 58, chapter 17b, Pharmacy Practice Act
  5. [5]Utah Administrative Code R156-17b-616, Operating standards, Class D pharmacy, out of state mail service pharmacies
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  8. [8]21 U.S.C. 331, Prohibited acts